Clinical Trials Directory

Trials / Completed

CompletedNCT03072602

Racial Differences in the Natriuretic Peptide Response to Glucose Challenge

A Study of Racial Differences in Natriuretic Peptides Response to Glucose Challenge

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to discover any racial dissimilarity in the response of Natriuretic peptide (NP) system to acute metabolic influences such as a high carbohydrate challenge

Detailed description

Previous studies have shown an association between reduced levels of circulating natriuretic peptides (NPs) and obesity in humans. This association is especially pronounced in those with metabolic syndrome traits and elevated plasma insulin. As previously conducted study has shown that an increase in NPs with weight loss in obese individuals is "primary" and not secondary to alteration in cardiac structure or function. Previous experimental data suggests that Atrial NP (ANP) has a wide range of favorable metabolic effects including that activation of brown fat and improvement in skeletal muscle oxidative capacity and glucose utilization. New evidence suggests that ANP activation directly modulates insulin sensitivity and energy homeostasis, suggesting that ANP suppression could promote more obesity/insulin resistance. Moreover, ANP exerts potent lipolytic effects in vitro and in vivo. The previous study has shown that a high-carbohydrate challenge in healthy volunteers is associated with a reduction in N-terminal-proANP (NTproANP) but not N-terminal-proB-type NP (NTproBNP) levels. Nonetheless our outcomes were predominantly in Caucasians and warrants replication in other racial groups. There is no data on the ANP response to high-carbohydrate challenge in African Americans, a racial group with disproportionately greater rates of obesity, insulin resistance, and diabetes as compared to Caucasians. So the investigators have proposed to conduct a pilot study in otherwise healthy, normotensive subjects to examine NP system, especially the effects on MRproANP in response of high-carbohydrate challenge.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTStudy dietParticipants will consume the study diet for 3 days provided by the clinical research unit's metabolic kitchen (at UAB).
OTHERGlucose ChallengeParticipants will come in fasting state on the main study visit day and will be given 75 gm oral glucose solution to drink, followed by blood collection every hour for next 8 hours.

Timeline

Start date
2017-03-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2017-03-07
Last updated
2023-06-22
Results posted
2021-09-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03072602. Inclusion in this directory is not an endorsement.